Response assessment of somatostatin receptor targeted radioligand therapies for progressive intracranial meningioma

被引：10
|
作者：
Muether, Michael [1 ]
Roll, Wolfgang [2 ]
Brokinkel, Benjamin [1 ]
Zinnhardt, Bastian [3 ]
Sporns, Peter B. [4 ]
Seifert, Robert [2 ]
Schafers, Michael [3 ]
Weckesser, Matthias [2 ]
Stegger, Lars [2 ]
Stummer, Walter [1 ]
Rahbar, Kambiz [2 ]
机构：
[1] Univ Hosp Munster, Dept Neurosurg, Munster, Germany
[2] Univ Hosp Munster, Dept Nucl Med, Munster, Germany
[3] WWU, European Inst Mol Imaging, Munster, Germany
[4] Univ Hosp Munster, Inst Clin Radiol, Munster, Germany
来源：
NUKLEARMEDIZIN-NUCLEAR MEDICINE | 2020年 / 59卷 / 05期
关键词：
Lu-177-DOTATATE; PRRT; meningioma; RADIONUCLIDE THERAPY; PET; Y-90-DOTATOC; GUIDELINES; RECURRENT; EANM;
D O I：
10.1055/a-1200-0989
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Zusammenfassung
引用
收藏
页码：348 / 355
页数：8
相关论文
共 50 条
  • [31] Epidermal growth factor receptor dimerization status determines response to HER-kinase targeted therapies in keratinocytes
    Laux, I
    Jain, A
    Tindell, CA
    Agus, DB
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 210S - 210S
  • [32] Diffusion-Weighted MRI in the Assessment of Tumor Response to Novel Targeted Therapies in Metastatic Renal Cell Carcinoma
    Bharwani, N.
    Miquel, M.
    Sahdev, A.
    Powles, T.
    Reznek, R.
    Rockall, A.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (05)
  • [33] Feasibility, tolerability and response of fractionated radioligand therapies with Bi-213-FAPI46: preliminary experience in 6 patients with end-stage, progressive metastatic tumors
    Helisch, Andreas
    Kratochwil, Clemens
    Rosales Castillo, Juan
    Dendl, Katharina
    Rathke, Hendrik
    Schreckenberger, Mathias
    Giesel, Frederik
    Jaeger, Dirk
    Haberkorn, Uwe
    Roehrich, Manuel
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [34] Monitoring of targeted therapies in advanced gastrointestinal stromal tumours: Comparison of tumour-response assessment according to RECIST with volumetry
    Schramm, N.
    Schlemmer, M.
    Englhart, E.
    Nikolaou, K.
    Becker, C.
    Reiser, M.
    Berger, F.
    ONKOLOGIE, 2010, 33 : 184 - 184
  • [35] A promising I-123 labeled radioligand for imaging neuroinflammation response by assessment P2X7 receptor expression
    Jin, Hongjun
    Han, Junbin
    Liu, Hui
    Yue, Xuyi
    Schoch, Kathleen
    Miller, Timothy
    Tu, Zhude
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [36] Integrative analysis of multi-platform reverse-phase protein array data for the pharmacodynamic assessment of response to targeted therapies
    Adam Byron
    Stephan Bernhardt
    Bérèngere Ouine
    Aurélie Cartier
    Kenneth G. Macleod
    Neil O. Carragher
    Vonick Sibut
    Ulrike Korf
    Bryan Serrels
    Leanne de Koning
    Scientific Reports, 10
  • [37] Integrative analysis of multi-platform reverse-phase protein array data for the pharmacodynamic assessment of response to targeted therapies
    Byron, Adam
    Bernhardt, Stephan
    Ouine, Berengere
    Cartier, Aurelie
    Macleod, Kenneth G.
    Carragher, Neil O.
    Sibut, Vonick
    Korf, Ulrike
    Serrels, Bryan
    de Koning, Leanne
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [38] Role of Ga-68 Somatostatin Receptor PET/CT in the Assessment of Response to Radiofrequency Ablation in Hepatic Metastases of Neuroendocrine Tumors
    Kulkarni, H.
    Kaemmerer, D.
    Petrovich, A.
    Hoersch, D.
    Baum, R. P.
    Hommann, M.
    NEUROENDOCRINOLOGY, 2012, 96 : 42 - 42
  • [39] Nomogram Analysis for Predicting Response to Androgen-Receptor-Axis-Targeted Therapies in Patients With Metastatic Castration-Resistant Prostate Cancer
    Shao, I-Hung
    Wang, Hsiang-Shen
    Hsieh, Chin-Hsuan
    Lee, Tsung-Lin
    Chang, Ying-Hsu
    Huang, Liang-Kang
    Chu, Yuan-Cheng
    Kan, Hung-Chen
    Lin, Po-Hung
    Yu, Kai-Jie
    Wu, Chun-Te
    Chuang, Cheng-Keng
    Pang, See-Tong
    CANCER MEDICINE, 2024, 13 (21):
  • [40] Does Molecular Response Assessment after Peptide Receptor Radionuclide Therapy using Ga-68 Somatostatin Receptor PET/CT Offer an Additional Benefit?
    Kulkarni, H. R.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S200 - S200
12345